LIVNLivaNova PLC

$76.39+39% 1Y

$76.39

$49.5752 weeks$85.43

Is the price fair?

Mixed

Growth expectations in line with delivery. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

What the price assumes~+11% a yearderived · Jun 30, 2026

Priced for ~11% a year FCF growth. Roughly in line with its three-year revenue growth of 11% a year.

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What LIVN's price assumes

LivaNova PLC trades at 22.6× earnings against 26.2× for the median Medical Devices name, cheaper than its own group.

22.6

Trailing P/E · Medical Devices median 26.2 · cheaper than the typical name in its group

Price / sales: 3.10
Price / sales · as of 2026-Q2
Free cash flow yield: 3.3%
Free cash flow yield · Medical Devices median 4.5%
Growth the price implies: +11%
Growth the price implies · The price pays for +11% free cash flow growth a year for a decade; the business has delivered +73% a year over the last three.